Application 209922
- Type
- ANDA
- Sponsor
- PRINSTON INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 10MEQ | No | No |
| 002 | POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 15MEQ | No | No |
| 003 | POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 20MEQ | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 43547-549 | POTASSIUM CHLORIDE | potassium chloride extended-release | Solco Healthcare LLC | ANDA | Current |
| 43547-550 | POTASSIUM CHLORIDE | potassium chloride extended-release | Solco Healthcare LLC | ANDA | Current |
| 43547-551 | POTASSIUM CHLORIDE | potassium chloride extended-release | Solco Healthcare LLC | ANDA | Current |